Monocytopenia as a diagnostic clue to pediatric B-lymphoblastic leukemia with rare circulating blasts

Sunita Iyengar Park1, Beverly Barton Rogers

  • 1a Children's Healthcare of Atlanta, Pathology.

Insights

Low monocyte counts in peripheral blood flow cytometry may indicate occult B-lymphoblastic leukemia (B-LL) in children with cytopenias. Further bone marrow examination is recommended if monocytes are less than 1%.

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Flow Cytometry

Background:

  • B-lymphoblastic leukemia/lymphoma (B-LL) is the most common childhood cancer.
  • Rarely, circulating blasts (<1%) in peripheral blood may be missed by flow cytometry, leading to false negatives.
  • Cytopenias can obscure the diagnosis of B-LL.

Purpose of the Study:

  • To investigate the utility of monocyte counts in diagnosing B-LL when blasts are rare in peripheral blood.
  • To determine if monocyte percentage and absolute monocyte counts (AMCs) can serve as diagnostic clues for occult leukemia.

Main Methods:

  • Retrospective review of B-LL patients diagnosed between Jan 2009-Dec 2011.
  • Comparison of peripheral blood flow cytometry data, specifically monocyte percentages and AMCs, between B-LL patients with <1% blasts and negative controls with cytopenias.
  • Analysis included 130 B-LL cases and 39 control cases.

Main Results:

  • Leukemia patients with <1% blasts had significantly lower monocyte percentages (0.8% vs 7.1%, p<0.001) compared to controls.
  • 79% of leukemia patients had monocytes <1%, versus 8% in controls.
  • Absolute monocyte counts (AMCs) were significantly lower in leukemia patients (93% <100 cells/µL vs 28% in controls, p<0.001).

Conclusions:

  • Low monocyte percentage (<1%) and low AMCs in peripheral blood can be indicators of occult B-LL in children with cytopenias.
  • Acquiring more than 10,000 events in flow cytometry is crucial for adequate blast assessment.
  • If monocytes are <1% by flow cytometry in the context of cytopenias, bone marrow examination is recommended despite negative peripheral blood flow cytometry results.